Werba Rubin Papier Wealth Management Purchases 266 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Werba Rubin Papier Wealth Management raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 36.7% during the 2nd quarter, Holdings Channel.com reports. The firm owned 990 shares of the healthcare conglomerate’s stock after acquiring an additional 266 shares during the quarter. Werba Rubin Papier Wealth Management’s holdings in UnitedHealth Group were worth $504,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently modified their holdings of UNH. Macroview Investment Management LLC boosted its holdings in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares during the period. True Wealth Design LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $31,000. Delos Wealth Advisors LLC boosted its position in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after acquiring an additional 53 shares during the period. Bbjs Financial Advisors LLC purchased a new stake in UnitedHealth Group in the 2nd quarter worth approximately $31,000. Finally, Signature Resources Capital Management LLC grew its position in shares of UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 18 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the subject of several research analyst reports. Royal Bank of Canada lifted their price objective on UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. UBS Group upped their price objective on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. Argus boosted their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research report on Monday, August 19th. One analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $614.17.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded up $1.39 during trading on Friday, reaching $596.88. 2,926,369 shares of the company traded hands, compared to its average volume of 4,070,939. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm has a 50 day simple moving average of $558.98 and a 200-day simple moving average of $515.11. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $607.94. The stock has a market capitalization of $549.36 billion, a PE ratio of 36.48, a P/E/G ratio of 1.68 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. The business had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm’s revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the company earned $6.14 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.41%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s payout ratio is 51.34%.

Insider Activity

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.